Catalog Number 96181 |
Device Problem
Improper or Incorrect Procedure or Method (2017)
|
Patient Problems
Visual Impairment (2138); Foreign Body Embolism (4439)
|
Event Date 03/08/2021 |
Event Type
Injury
|
Manufacturer Narrative
|
The events of vascular occlusion and vision abnormalities are a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.Clarification: the filler was injected into the patient and is not accessible for return.The syringe was discarded.A review of the device history record has been initiated.If any new, changed or corrected information is noted, a supplemental medwatch will be submitted.This is a known potential adverse event addressed in the product labeling.
|
|
Event Description
|
Health professional reported injecting a patient in the lateral half of the tear troughs with 0.3 cc of juvéderm volbella® xc on each side.That day, the patient experienced ¿vascular occlusion and some mottling to the right cheek¿ with ¿double vision¿ the next day.The patient was treated the same day with hylenex.The event is ongoing.
|
|
Manufacturer Narrative
|
A review of the device history record has been completed.No deviations or non-conformances noted.Additional, changed, and/or corrected data.
|
|
Event Description
|
Health professional reported injecting a patient in the lateral half of the tear troughs with 0.3 cc of juvéderm volbella® xc on each side.That day, the patient experienced ¿vascular occlusion and some mottling to the right cheek¿ with ¿double vision¿ the next day.The patient was treated the same day with hylenex.The event is ongoing.
|
|
Search Alerts/Recalls
|